BMS-929075 is under investigation in clinical trial NCT01525212 (Multiple Ascending Dose Study of BMS-929075 in Hepatitis C Virus (HCV) Infected Patients).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.